Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Granule for common cold (wind-cold syndrome)
ChiCTR2100045269Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jingfang Granules in nasopharyngitis (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Disease recovery time. Started Jan 2021; status: recruiting.
02
Drugs
Jingfang Granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR2100045269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045269.